7th Annual Glioblastoma Summit: Trailblazing Next-Generation Glioblastoma & Glioma Therapies February 19, 2026 at 10:00 AM EST Supporting Materials Surmounting Barriers in Non-resectable Recurrent Glioblastoma with a Single Treatment of Bizaxofusp, an Engineered IL-4R Directed Fusion Protein 2.6 MB Location Boston, MA
Surmounting Barriers in Non-resectable Recurrent Glioblastoma with a Single Treatment of Bizaxofusp, an Engineered IL-4R Directed Fusion Protein 2.6 MB
